<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136339">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02127580</url>
  </required_header>
  <id_info>
    <org_study_id>EASE-IT</org_study_id>
    <nct_id>NCT02127580</nct_id>
  </id_info>
  <brief_title>Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve</brief_title>
  <acronym>EASE-IT</acronym>
  <official_title>Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve (EASE-IT) A Two-armed Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut für Pharmakologie und Präventive Medizin</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is limited experience for the balloon expandable THV (transcatheter heart valve) on
      the need for predilation (ballon aortic valvuloplasty, BAV). Therefore we aim to verify
      results of a small case series published by Wendler et. al. to examine hard endpoints such
      as the incidence of cerebrovascular complications, paravalvular leakage and operative
      outcomes in a multicenter registry.

      We aim to compare the implantation of balloon expandable transcatheter heart valves with or
      without predilation with respect to procedural outcomes (VARC2).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior to the deployment of transcatheter heart valves (THV), balloon aortic valvuloplasty
      (BAV) is usually performed under rapid right ventricular pacing (burst &gt;180 bpm) with the
      induction of a functional cardiac arrest for up to 30 seconds. Aortic valve predilation is
      aiming at facilitating the crossing of the aortic annulus, accurate valve positioning and
      does also provide information on the anatomy of the valve complex. However, BAV has been
      shown to have a number of potentially detrimental effects, such as:

        -  Functional cardiac arrest induced by rapid pacing leads to transient coronary,
           cerebral, and renal ischemia.

        -  In patients with a reduced left ventricular ejection fraction (LVEF), prolonged cardiac
           depression after rapid pacing is observed and may result in hemodynamic failure and
           systemic inflammatory response syndrome (SIRS). Both are associated with a high
           periprocedural mortality.

        -  BAV has been identified as a major source of thrombotic and valvular material and
           increases the risk for coronary obstruction with subsequent myocardial infarction and
           stroke.

        -  The local trauma in the left-ventricular outflow tract caused by BAV may potentially
           contribute to aortic root rupture.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>VARC2 criteria</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>comparison of the implantation of balloon expandable transcatheter heart valves with or without predilation with respect to procedural outcomes (VARC2).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>with BAV</arm_group_label>
    <description>Patients undergoing TA-TAVI WITH predilation of the AV (Group A)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without BAV</arm_group_label>
    <description>Patients undergoing TA-TAVI WITHOUT predilation of the AV</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BAV</intervention_name>
    <arm_group_label>with BAV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no BAV</intervention_name>
    <arm_group_label>without BAV</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from aortic Stenosis undergoing transapical trans-catheter heart valve
        implantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with an indication for TAVI as to the Edwards THV IFU

          -  Eligible for TABI with AND without BAV

          -  Signed informed consent

        Exclusion Criteria:

          -  Logistic EuroSCORE I &gt;50%

          -  Mitral or tricuspid valvular insufficiency (&gt; grade II)

          -  Previous aortic valve replacement

          -  Uncontrolled atrial fibrillation

          -  Left ventricular or atrial thrombus by echocardiography

          -  Recent cerebrovascular event (within the last 3 months)

          -  High probability of non-adherence to the follow-up requirements (due to social,
             psychological or medical reasons)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Schröfel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Cardiac Surgery Karlsruhe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Justus Strauch, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Herz- und Thoraxchirurgie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinic for Cardiac Surgery Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Württemberg</state>
        <zip>76185</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Schröfel, MD</last_name>
      <phone>+49 721 9738131</phone>
    </contact>
    <investigator>
      <last_name>Holger Schröfel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Herz- und Thoraxchirurgie, BG-Uniklinikum Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justus Strauch, Prof.</last_name>
      <phone>+49 234 3026000</phone>
    </contact>
    <investigator>
      <last_name>Justus Strauch, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>April 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>THV</keyword>
  <keyword>BAV</keyword>
  <keyword>pre-dilation</keyword>
  <keyword>Aortic valve stenosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
